{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:19:57Z","timestamp":1776449997702,"version":"3.51.2"},"publisher-location":"Chichester, UK","reference-count":61,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd008989.pub2","type":"reference-entry","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T19:54:53Z","timestamp":1334260493000},"source":"Crossref","is-referenced-by-count":24,"title":["Long-acting beta<sub>2<\/sub>-agonist in addition to tiotropium versus either tiotropium or long-acting beta<sub>2<\/sub>-agonist alone for chronic obstructive pulmonary disease"],"prefix":"10.1002","author":[{"given":"Charlotta","family":"Karner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J","family":"Cates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,4,18]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD008989.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1155\/2004\/394710","article-title":"The Canadian optimal therapy of COPD trial: Design, organization and patient recruitment","volume":"11","author":"Aaron","year":"2004","journal-title":"Canadian Respiratory Journal"},{"issue":"8","key":"10.1002\/14651858.CD008989.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-146-8-200704170-00152","article-title":"Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.[see comment][summary for patients in Ann Intern Med. 2007 Apr 17;146(8):I12; PMID: 17310044]","volume":"146","author":"Aaron","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008989.pub2-BIB3|cit3","first-page":"258","article-title":"Effects of tiotropium combined with either salmeterol or salmeterol\/fluticasone in moderate to severe COPD","volume":"16","author":"Kaplan","year":"2007","journal-title":"Primary Care Respiratory Journal"},{"issue":"11","key":"10.1002\/14651858.CD008989.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/thx.2007.089557","article-title":"Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD","volume":"63","author":"Najafzadeh","year":"2008","journal-title":"Thorax"},{"issue":"6","key":"10.1002\/14651858.CD008989.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0761-8417(07)78518-8","article-title":"Tiotropium in combination with placebo, salmeterol, or fluticasone- salmeterol for treatment of chronic obstructive pulmonary disease. A randomized trial","volume":"63","author":"Roisman","year":"2007","journal-title":"Revue de Pneumologie Clinique"},{"key":"10.1002\/14651858.CD008989.pub2-BIB6|cit6","unstructured":"A randomized, double-blind, controlled, parallel group, 12-week treatment study to compare the efficacy and safety of the combination of indacaterol 150 \u03bcg once daily with open label tiotropium 18 \u03bcg once daily versus open label tiotropium 18 \u03bcg once daily in patients with moderate-to-severe chronic obstructive pulmonary disease www.novctrd.com"},{"key":"10.1002\/14651858.CD008989.pub2-BIB7|cit7","series-title":"American Journal of Respiratory and Critical Care Medicine","article-title":"Combining once-daily bronchodilators In COPD: Indacaterol plus tiotropium versus tiotropium alone","author":"Mahler","year":"2011"},{"key":"10.1002\/14651858.CD008989.pub2-BIB8|cit8","unstructured":"A randomized, double-blind, controlled, parallel group, 12-week treatment study to compare the efficacy and safety of the combination of indacaterol 150 \u03bcg once daily with open label tiotropium 18 \u03bcg once daily versus open label tiotropium 18 \u03bcg once daily in patients with moderate-to-severe chronic obstructive pulmonary disease www.novctrd.com"},{"key":"10.1002\/14651858.CD008989.pub2-BIB9|cit9","series-title":"American Journal of Respiratory and Critical Care Medicine","article-title":"Combining once-daily bronchodilators In COPD: Indacaterol plus tiotropium versus tiotropium alone","author":"Mahler","year":"2011"},{"key":"10.1002\/14651858.CD008989.pub2-BIB10|cit10","series-title":"Journal of Allergy and Clinical Immunology","first-page":"S4 [13]","article-title":"Formoterol treatment plus tiotropium results in greater improvements in lung function compared with tiotropium administered alone in patients with COPD [Abstract]","author":"Tashkin","year":"2007"},{"key":"10.1002\/14651858.CD008989.pub2-BIB11|cit11","series-title":"Chest","first-page":"529a","article-title":"The therapeutic effect of treatment with formoterol plus tiotropium was greater than the effect of treatment with tiotropium alone in COPD: findings from a 12-week, multicenter, double-blind, placebo-controlled, trial","author":"Tashkin","year":"2007"},{"key":"10.1002\/14651858.CD008989.pub2-BIB14|cit12","series-title":"American Thoracic Society International Conference, May 16-21, 2008, Toronto","first-page":"A647[#F5]","article-title":"Formoterol and tiotropium reduces rescue medication use more than tiotropium alone in patients with moderate COPD: findings from a 12 week randomized placebo controlled trial [Abstract]","author":"Tashkin","year":"2008"},{"issue":"1","key":"10.1002\/14651858.CD008989.pub2-BIB12|cit13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/15412550902724073","article-title":"Formoterol and tiotropium compared with tiotropium alone for treatment of COPD","volume":"6","author":"Tashkin","year":"2009","journal-title":"COPD: Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1002\/14651858.CD008989.pub2-BIB13|cit14","series-title":"Chest","first-page":"103002s","article-title":"Improvement of lung function with coadministered formoterol and tiotropium, regardless of smoking status in patients with chronic obstructive pulmonary disease [Abstract]","author":"Tashkin","year":"2008"},{"key":"10.1002\/14651858.CD008989.pub2-BIB15|cit15","series-title":"European Respiratory Journal","first-page":"440s [P2514]","article-title":"Formoterol given either alone or together with tiotropium reduces the rate of exacerbations in stable COPD patients [Abstract]","author":"Arievich","year":"2006"},{"key":"10.1002\/14651858.CD008989.pub2-BIB16|cit16","unstructured":"Novartis A randomized, multi-center, placebo controlled 24 week study to compare the efficacy and safety of formoterol Certihaler 10\u03bcg b.i.d., tiotropium HandiHaler 18\u03bcg o.d. and tiotropium HandiHaler 18\u03bcg o.d. in combination with formoterol Certihaler 10\u03bcg b.i.d. in patients with stable Chronic Obstructive Pulmonary Disease. www.novctrd.com"},{"issue":"11","key":"10.1002\/14651858.CD008989.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.rmed.2008.07.020","article-title":"Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study","volume":"102","author":"Vogelmeier","year":"2008","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD008989.pub2-BIB18|cit18","series-title":"European Respiratory Journal","first-page":"429s [P2506]","article-title":"Formoterol and tiotropium both improve lung function in stable COPD patients with some additional benefit when given together [Abstract]","author":"Vogelmeier","year":"2006"},{"key":"10.1002\/14651858.CD008989.pub2-BIB19|cit19","series-title":"European Respiratory Journal","first-page":"26s","article-title":"A comparative trial of tiotropium, salmeterol and placebo: health-related quality of life","author":"Bateman","year":"2001"},{"key":"10.1002\/14651858.CD008989.pub2-BIB20|cit20","series-title":"American Thoracic Society 99th International Conference","first-page":"B024 Poster 420","article-title":"Flow and volume responders following treatment with tiotropium and salmeterol in patients with COPD [abstract]","author":"Brusasco","year":"2003"},{"key":"10.1002\/14651858.CD008989.pub2-BIB21|cit21","series-title":"European Respiratory Journal","first-page":"Abstract No: [P","article-title":"A single dose of formoterol (FOR) and tiotropium (TIO) reduce hyperinflation in COPD patients [Abstract]","author":"Marco","year":"2003"},{"key":"10.1002\/14651858.CD008989.pub2-BIB22|cit22","series-title":"Respirology","first-page":"A164","article-title":"Comparison of clinical efficacy of tiotropium and salmeterol for pulmonary function, air-trapping, exercise capacity, and HRQO in COPD [Abstract]","author":"Fujimoto","year":"2007"},{"key":"10.1002\/14651858.CD008989.pub2-BIB23|cit23","series-title":"Respiratory Care","first-page":"1081","article-title":"A comparison of maintenance tiotropium and salmeterol on arterial blood gas tensions in patients with COPD [Abstract]","author":"Gross","year":"2003"},{"key":"10.1002\/14651858.CD008989.pub2-BIB24|cit24","unstructured":"Jones CDS The combined effect of tiotropium and formoterol on the functional status of patients with moderate-to-severe COPD [Dissertation] CINAHL Accession Number: 2011033276\/\/UMI Order AAI3408930 2010 144 p"},{"key":"10.1002\/14651858.CD008989.pub2-BIB25|cit25","series-title":"American Thoracic Society International Conference, May 16-21, 2008, Toronto","first-page":"A646[#F1]","article-title":"Effect of formoterol, salbutamol and tiotropium bromide on the efficacy of lung clearance in patients with COPD [Abstract]","author":"Meyer","year":"2008"},{"key":"10.1002\/14651858.CD008989.pub2-BIB26|cit26","series-title":"American Thoracic Society International Conference, May 15-20, 2009, San Diego","first-page":"A4541 [Poster #","article-title":"Adding nebulized formoterol to tiotropium treatment provides added benefits in pulmonary function, dyspnea and rescue medication use: a pooled analysis [Abstract]","author":"New","year":"2009"},{"key":"10.1002\/14651858.CD008989.pub2-BIB27|cit27","series-title":"American Thoracic Society International Conference, May 18-23, 2007, San Francisco, California, USA","first-page":"Poster #M72","article-title":"Bronchodilation improves endurance but not muscular efficiency in COPD [Abstract]","author":"Hacken","year":"2007"},{"key":"10.1002\/14651858.CD008989.pub2-BIB28|cit28","series-title":"European Respiratory Journal","first-page":"Abstract No: 15","article-title":"Relation between the aute response to salbutamol and long term FEV1 responses to tiotropium (TIO), formoterol (FORM) and its combination (T=F) in COPD patients [abstract]","author":"Noord","year":"2003"},{"key":"10.1002\/14651858.CD008989.pub2-BIB29|cit29","series-title":"American Thoracic Society 99th International Conference","first-page":"B024 Poster 421","article-title":"Comparison of once daily tiotropium, twice daily formoterol and the free combination, once daily, in patients with COPD [abstract]","author":"Noord","year":"2003"},{"key":"10.1002\/14651858.CD008989.pub2-BIB30|cit30","series-title":"American Thoracic Society 2005 International Conference; May 20-25; San Diego, California","first-page":"[B93] [Poster:","article-title":"The effect of tiotropium, salmeterol and it's combination on dynamic hyperinflation in COPD [Abstract]","author":"Noord","year":"2005"},{"issue":"3","key":"10.1002\/14651858.CD008989.pub2-BIB31|cit31","article-title":"Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease","author":"Appleton","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008989.pub2-BIB32|cit32","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002876.pub2","article-title":"Tiotropium for stable chronic obstructive pulmonary disease","author":"Barr","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008989.pub2-BIB33|cit33","doi-asserted-by":"crossref","unstructured":"Beeh KM Beier J Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases Advances in Therapy 2009 691 9","DOI":"10.1007\/s12325-009-0044-3"},{"key":"10.1002\/14651858.CD008989.pub2-BIB34|cit34","doi-asserted-by":"crossref","unstructured":"Beier J Beeh KM Long-acting beta-adrenoceptor agonists in the management of COPD: focus on indacaterol International Journal of Chronic Obstructive Pulmonary Disease 2011 237 43","DOI":"10.2147\/COPD.S7371"},{"issue":"2","key":"10.1002\/14651858.CD008989.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.rmed.2007.09.011","article-title":"Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease","volume":"102","author":"Berger","year":"2008","journal-title":"Respiratory Medicine"},{"issue":"8","key":"10.1002\/14651858.CD008989.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008989.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pupt.2010.03.003","article-title":"The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD","volume":"23","author":"Cazzola","year":"2010","journal-title":"Pulmonary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD008989.pub2-BIB38|cit38","doi-asserted-by":"crossref","unstructured":"Celli B Decramer M Leimer I Vogel U Kesten S Tashkin DP Cardiovascular safety of tiotropium in patients with COPD Chest 2010 20 30","DOI":"10.1378\/chest.09-0011"},{"issue":"9","key":"10.1002\/14651858.CD008989.pub2-BIB39|cit39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009552.pub2","article-title":"Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease","author":"Cheyne","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008989.pub2-BIB40|cit40","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002990.pub2","article-title":"Self-management education for patients with chronic obstructive pulmonary disease","author":"Effing","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008989.pub2-BIB41|cit41","unstructured":"Global Initiative for Chronic Obstructive Lung Disease Global Strategy for Diagnosis, Management, and Prevention of COPD http:\/\/www.goldcopd.com 2009"},{"key":"10.1002\/14651858.CD008989.pub2-BIB42|cit42","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]","author":"Higgins","year":"2008"},{"issue":"5","key":"10.1002\/14651858.CD008989.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1164\/ajrccm.158.supplement_2.13tac110","article-title":"Acute care costs of patients admitted for management of chronic obstructive pulmonary disease exacerbations: contribution of disease severity, infection and chronic heart failure","volume":"40","author":"Hutchinson","year":"2010","journal-title":"Internal Medicine Journal"},{"issue":"5 Pt 3","key":"10.1002\/14651858.CD008989.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1164\/ajrccm.158.supplement_2.13tac110","article-title":"The beta-adrenoceptor","volume":"158","author":"Johnson","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD008989.pub2-BIB45|cit45","article-title":"Combination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease","author":"Karner","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008989.pub2-BIB46|cit46","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003793.pub2","article-title":"Pulmonary rehabilitation for chronic obstructive pulmonary disease","author":"Lacasse","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008989.pub2-BIB47|cit47","doi-asserted-by":"crossref","unstructured":"Moen MD Indacaterol: in chronic obstructive pulmonary disease Drugs 2010 2269 80","DOI":"10.2165\/11203960-000000000-00000"},{"issue":"11","key":"10.1002\/14651858.CD008989.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/thx.2007.089557","article-title":"Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD","volume":"63","author":"Najafzadeh","year":"2008","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD008989.pub2-BIB49|cit49","unstructured":"National Institute for Health and Clinical Excellence Chronic obstructive pulmonary disease, Costing report, Implementing NICE guidance http:\/\/guidance.nice.org.uk\/CG101\/CostingReport\/pdf\/English"},{"issue":"4","key":"10.1002\/14651858.CD008989.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"305-10; discuss","DOI":"10.1513\/pats.200504-038SR","article-title":"Beta2-agonist and anticholinergic drugs in the treatment of lung disease","volume":"2","author":"Proskocil","year":"2005","journal-title":"Proceedings of the American Thoracic Society"},{"key":"10.1002\/14651858.CD008989.pub2-BIB51|cit51","unstructured":"The Nordic Cochrane Centre; Cochrane Collaboration Review Manager (RevMan) Version 5 2008"},{"issue":"5","key":"10.1002\/14651858.CD008989.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1378\/chest.07-1167","article-title":"Safety of Long-Acting \u03b2-Agonists in Stable COPD*","volume":"133","author":"Rodrigo","year":"2008","journal-title":"Chest"},{"key":"10.1002\/14651858.CD008989.pub2-BIB53|cit53","unstructured":"Jones P St George's Respiratory Questionnaire for COPD Patients (SGRQ-C) St George\u2019s, University of London 2008"},{"issue":"2","key":"10.1002\/14651858.CD008989.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/ebm.14.2.42","article-title":"Review: inhaled anticholinergics increase risk of major cardiovascular events in COPD","volume":"14","author":"Singh","year":"2009","journal-title":"Evidence Based Medicine"},{"issue":"7","key":"10.1002\/14651858.CD008989.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1440-1681.2005.04222.x","article-title":"New insights into beta-adrenoceptors in smooth muscle: distribution of receptor subtypes and molecular mechanisms triggering muscle relaxation","volume":"32","author":"Tanaka","year":"2005","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"15","key":"10.1002\/14651858.CD008989.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A 4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"New England Journal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008989.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.rmed.2007.12.019","article-title":"Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial","volume":"102","author":"Tashkin","year":"2008","journal-title":"Respiratory Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008989.pub2-BIB58|cit58","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002999","article-title":"Smoking cessation for chronic obstructive pulmonary disease","author":"Meer","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD008989.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00059-002-2434-z","article-title":"The beta-adrenergic receptors","volume":"27","author":"Wallukat","year":"2002","journal-title":"Herz"},{"issue":"5","key":"10.1002\/14651858.CD008989.pub2-BIB60|cit60","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007891.pub3","article-title":"Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease","author":"Welsh","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008989.pub2-BIB61|cit61","unstructured":"World Health Organization Chronic Respiratory Diseases www.who.int"}],"updated-by":[{"DOI":"10.1002\/14651858.cd008989.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T00:00:00Z","timestamp":1445472000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008989.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T20:08:37Z","timestamp":1742933317000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD008989.pub2"}},"subtitle":[],"editor":[{"given":"Charlotta","family":"Karner","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,18]]},"references-count":61,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008989.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD008989.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2012,4,18]]}}}